Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
This study is looking for better ways to find out if pancreatic cysts (fluid-filled sacs in the pancreas) have changes that could become cancer. Researchers are testing new methods using samples of your blood, stool, pancreatic juice, and cyst fluid. You might be able to join if you are 18 or older, have certain types of pancreatic cysts (Fukuoka worrisome or high-risk criteria), and have not had pancreatic cancer or surgery before. The study aims to see if these new tests can help diagnose high-grade dysplasia (pre-cancerous cells) or cancer within 5 years. The current status of this study is unclear.
- Study design
- This interventional study plans to enroll 800 participants. Participants will be assigned to either an Immediate Surgery group or a Clinical Follow-up group based on their doctor's decision.
- What's involved
- You would provide blood and stool samples at the beginning of the study. If you are in the Immediate Surgery group, you might also have pancreatic juice collected and undergo pancreatic surgery or an endoscopy exam (endoscopic ultrasound).
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure outcomes related to biospecimen acquisition and cancer diagnosis for 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Shounak Majumder, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Biospecimen Acquisition5 years
Number of biospecimens collected
- High grade dysplasia (HGD) or cancer diagnosis in Immediate Surgery group5 years
To validate the diagnostic accuracy of cyst fluid methylated DNA marker (MDM) assays for detection of HGD and cancer in pancreatic cysts undergoing surgical resection